Morgan Stanley upgrades Franklin Resources stock rating on turnaround signs

Morgan Stanley upgraded Franklin Resources from Underweight to Equalweight and raised its price target to $31 from $21, implying about 4% upside from the $30.46 share price. The firm cited improving business momentum, stabilizing flows, and a turnaround in the asset manager’s fundamentals, though secular fee-compression pressures remain. Franklin also reported fiscal Q2 2026 EPS of $0.71 versus $0.55 expected and revenue of $2.29 billion versus $1.7 billion expected, with AUM at $1.74 trillion.

Analysis

BEN is moving from a “prove-it” story to a lower-volatility re-rating candidate: the key change is not just better flows, but reduced probability of another negative surprise at the operating line. In asset managers, the market typically pays for durability of inflows and margin stability before it pays for absolute growth, so even modest improvement in alternatives and fixed income fundraising can justify a multiple step-up faster than earnings revisions alone would suggest.

The second-order effect is that the market may be underestimating how quickly a cleaner flow profile can compress the discount rate applied to franchise value. If the business can keep Western-related drag behind it for two to three quarters, the stock can trade more like a stable fee compounder than a melting-ice-cube value trap, which is the real setup behind the recent move. That said, the current valuation already prices in a fair amount of normalization; upside from here is more likely to come from continued multiple expansion than from near-term EPS beats.

The main risk is that this becomes a crowded “turnaround is here” consensus before the fundamentals have fully reset. Asset managers tend to look best late in the cycle when markets are supportive and flows are stabilizing, but that also means a drawdown in equities or a reversal in rate expectations can quickly expose the structural fee pressure again. Over the next 1-3 months, the stock likely trades on flow headlines and analyst upgrades; over 6-12 months, the decisive variable is whether higher-growth products can offset legacy runoff enough to sustain a premium multiple.

Contrarian takeaway: the market may be focusing too much on the recovery narrative and not enough on the quality of that recovery. If the improvement is being driven by market beta and non-operating items more than persistent organic demand, the stock can be “right” on the quarter but wrong on the year. That favors owning BEN only if paired against higher-quality asset gatherers rather than as a naked long.

Key Decisions for Investors

• Buy BEN on pullbacks toward the low end of the post-upgrade range, with a 3-6 month target for continuation toward the low-$30s; risk/reward is acceptable only if flow momentum remains positive for another 1-2 earnings cycles.
• For a cleaner expression of the turnaround, pair long BEN vs short a structurally weaker asset manager with declining flows and more exposed fee pressure over the next 1-2 quarters; this isolates the re-rating without taking broad market beta.
• If already long BEN, finance upside with a covered call around the next major resistance area; the stock is close enough to highs that upside is more likely to be incremental than explosive over the next 30-60 days.
• Avoid chasing BEN after upgrade headlines if you need a tactical entry; the better setup is a failed selloff on market weakness, where the downside is buffered by improving sentiment but the valuation still leaves limited room for disappointment.